Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Glioblastoma 8Gliosarcoma 7Brain Neoplasms 5Central Nervous System Neoplasms 4Osteosarcoma 2Oligodendroglioma 2Glioma 2Astrocytoma 2Untreated Childhood Anaplastic Astrocytoma 1Sarcoma, Synovial 1Sarcoma 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Meningioma 1Glioma, Subependymal 1

Interventions

Doxorubicin 142Ifosfamide 85Radiotherapy 82Cyclophosphamide 72Gemcitabine 63Filgrastim 54pembrolizumab 43pazopanib 40Etoposide 39Docetaxel 39Vincristine 37Trabectedin 37Cisplatin 35Nivolumab 32Magnetic Resonance Spectroscopy 26Irinotecan 26Carboplatin 25Temozolomide 23Surgical Procedures, Operative 23Radiation 22Ipilimumab 22Bevacizumab 20Blood Specimen Collection 19Granulocyte Colony-Stimulating Factor 18Biopsy 18eribulin 17Sirolimus 17Mesna 17Melphalan 17Dactinomycin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Gefitinib × Sarcoma × Clear all
NCT00052754 2012-09-24

Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
48 enrolled
Sarcoma

Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡